---
title: "Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297209220.md"
description: "On Thursday, the drug Tezspire, developed by Amgen and AstraZeneca, demonstrated effectiveness in treating an esophageal disease prevalent among approximately 470,000 patients in the United States. The success of Tezspire has raised speculations about its potential to compete with Dupixent, as reported by Investor's Business Daily."
datetime: "2026-08-27T15:16:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297209220.md)
  - [en](https://longbridge.com/en/news/297209220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297209220.md)
generator: "portal-rs"
---

# Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent?

On Thursday, the drug Tezspire, developed by Amgen and AstraZeneca, demonstrated effectiveness in treating an esophageal disease prevalent among approximately 470,000 patients in the United States. The success of Tezspire has raised speculations about its potential to compete with Dupixent, as reported by Investor's Business Daily.

### Related Stocks

- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)

## Related News & Research

- [UK regulator suspends Amgen's Tavneos for new patients over unreliable data](https://longbridge.com/en/news/297642592.md)
- [AstraZeneca Shares Dual Oncology Clinical and Regulatory Victories](https://longbridge.com/en/news/297649754.md)
- [Rare-Disease Drug Tavneos Faces UK Withdrawal](https://longbridge.com/en/news/297819339.md)
- [Key facts: LSE:AZN Zegfrovy buy; SANOVO PFS; Wan Ling Martello named](https://longbridge.com/en/news/297611733.md)
- [AstraZeneca, Daiichi Sankyo Get New EU Approval for Breast Cancer Drug](https://longbridge.com/en/news/297613676.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**